» Articles » PMID: 314367

Effects of Repeated Corynebacterium Parvum and BCG Therapy on Immune Parameters: a Weekly Sequential Study of Melanoma Patients. I. Changes in Non-specific (NK, K and T Cell) Lymphocytotoxicity, Peripheral Blood Counts and Delayed Hypersensitivity...

Overview
Date 1979 May 1
PMID 314367
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Increased lymphocyte cytotoxicity, particularly of 'killer' K cell type was recorded with repeated immunizations of either C. parvum or BCG. A 3 week interval between immunizations was capable of maintaining the increase in cytotoxicity. No marked alterations of 'recall' skin hypersensitivity reactions nor of peripheral blood counts were noted. Expression of cytotoxicity results as percentage 51Cr release, lytic units/ml and cytotoxic capacity (after logit transformation of the cytotoxicity-lymphocyte curves) are described. A 3 week immunization schedule is suggested where BCG and C. parvum are used as immunotherapeutic agents, in the doses quoted.

Citing Articles

Natural killer cells in human solid tumors.

Introna M, Mantovani A Cancer Metastasis Rev. 1983; 2(4):337-50.

PMID: 6203638 DOI: 10.1007/BF00048566.


Membrane glycoprotein M-2 protects against Leishmania amazonensis infection.

Champsi J, McMahon-Pratt D Infect Immun. 1988; 56(12):3272-9.

PMID: 3182080 PMC: 259734. DOI: 10.1128/iai.56.12.3272-3279.1988.


Suppression of murine NK activity induced by Corynebacterium parvum: further characterization and abrogation of suppressor cells.

Milisauskas V, CUDKOWICZ G, Nakamura I Cancer Immunol Immunother. 1986; 21(1):51-7.

PMID: 2935247 PMC: 11038136. DOI: 10.1007/BF00199377.


Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly study of melanoma patients II. Changes in serum immunoglobulins and lymphoid cell subpopulations.

Thatcher N, Swindell R, Crowther D Clin Exp Immunol. 1979; 36(3):456-64.

PMID: 487647 PMC: 1537740.

References
1.
Thatcher N, Palmer M, Swindell R, Crowther D . Lymphocyte function related to survival curves in patients with metastatic melanoma treated by chemoimmunotherapy. Med Pediatr Oncol. 1978; 4(1):59-70. DOI: 10.1002/mpo.2950040110. View

2.
Thatcher N, Palmer M, Gasiunas N, Crowther D . Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanoma. Br J Cancer. 1977; 36(6):751-62. PMC: 2025560. DOI: 10.1038/bjc.1977.258. View

3.
Thatcher N, Barnard R, Gasiunas N, Crowther D . Changes in cellular immunity following nephrectomy for localized and metastatic hypernephroma. Eur J Cancer (1965). 1977; 13(9):951-6. DOI: 10.1016/0014-2964(77)90171-2. View

4.
Berkelhammer J, Mastrangelo M, Laucius J, Bodurtha A, Prehn R . Sequential in vitro reactivity of lymphocytes from melanoma patients receiving immunotherapy compared with the reactivity of lymphocytes from healthy donors. Int J Cancer. 1975; 16(4):571-8. DOI: 10.1002/ijc.2910160407. View

5.
Hersey P, Edwards A, Edwards J . Characterization of mononuclear effector cells in human blood. Clin Exp Immunol. 1976; 23(1):104-13. PMC: 1538369. View